Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Equity (2016 - 2025)

Historic Return on Equity for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 0.23%.

  • Collegium Pharmaceutical's Return on Equity fell 1600.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.2% for FY2024, which is 400.0% down from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Return on Equity of 0.23% as of Q3 2025, which was down 1600.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Return on Equity registered a high of 0.5% during Q2 2021, and its lowest value of 0.22% during Q3 2022.
  • Over the past 5 years, Collegium Pharmaceutical's median Return on Equity value was 0.23% (recorded in 2025), while the average stood at 0.18%.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Return on Equity crashed by -6800bps in 2022, and later surged by 6000bps in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Equity (Quarter) stood at 0.32% in 2021, then tumbled by -140bps to 0.13% in 2022, then surged by 302bps to 0.26% in 2023, then grew by 16bps to 0.3% in 2024, then decreased by -23bps to 0.23% in 2025.
  • Its Return on Equity was 0.23% in Q3 2025, compared to 0.16% in Q2 2025 and 0.19% in Q1 2025.